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A B S T R A C T
Regular physical exercise has health beneﬁts and can prevent some of the ageing-associated muscle deteriora-
tions. However, the biochemical mechanisms underlying this exercise beneﬁt, especially in human tissues, are
not well known. To investigate, we assessed this using miRNA proﬁling, mRNA and protein levels of anti-oxidant
and metabolic proteins in the vastus lateralis muscle of master athletes aged over 65 years and age-matched
controls. Master athletes had lower levels of miR-7, while mRNA or protein levels of SIRT3, SIRT1, SOD2, and
FOXO1 levels were signiﬁcantly higher in the vastus lateralis muscle of master athletes compared to muscles of
age-matched controls. These results suggest that regular exercise results in better cellular metabolism and an-
tioxidant capacity via maintaining physiological state of mitochondria and eﬃcient ATP production and de-
creasing ageing-related inﬂammation as indicated by the lower level of miR-7 in master athletes.
1. Introduction
Skeletal muscle is the most abundant tissue in human body, ac-
counting for about 60% of the total protein content and 40% of body
mass. It is not only important for locomotion and maintenance of body
posture, but also has an important metabolic function such as storage of
carbohydrates in the form of glycogen. Aging results in signiﬁcant loss
in muscle mass and function, which directly eﬀects well-being and
mortality [1]. The loss of muscle mass is attributable to a gradual de-
cline in the number of muscle ﬁbers that begins around the age of 50,
where by the age of 80 approximately 50% of the ﬁbers are lost [2].
Physical exercise might be the only natural tool to attenuate sarcopenia.
Indeed, regular exercise has been shown to be associated with larger
muscle cross sectional area [3], ﬁber number [4,5], strength [6], en-
durance capacity [7], mitochondrial function [8], insulin sensitivity
[9], among others.
Aging is associated with alterations in the miRNA proﬁle in skeletal
muscle [10,11] and deterioration of mitochondrial function dynamics
[12–14]. Physical activity induces a wide range of functional and bio-
chemical changes in skeletal muscle including epigenetic changes, such
as alterations in the miRNA proﬁle [15–18]. For instance, both short-
[19] and long-term endurance exercise [20] induced changes in the
levels of a number of miRNAs that are involved in the regulation of
skeletal muscle regeneration, gene expression and mitochondrial bio-
genesis. These eﬀects of endurance training are not limited to healthy
people, but also in patients with polymyositis or dermatomyositis en-
durance exercise induced an increase in muscle miRNA levels that
target transcripts involved in inﬂammation, metabolism and muscle
atrophy [21]. Hypertrophic stimuli can also induce changes in miRNA
levels as illustrated by our observation that functional mechanical
overloading by synergist muscle ablation induced alterations in miRNA
levels that control atrophy and hypertrophy [22]. It is thus possible that
regular exercise can reverse some of the detrimental ageing-related
changes in the miRNA proﬁle and mitochondrial function.
Since ageing is associated with reduced levels of physical activity
[23] and disuse does cause muscle wasting and reductions in oxidative
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capacity [24] master athletes (athletes 35 years and older) may provide
an excellent model to study the eﬀects of ageing per se on muscle, not
confounded by disuse [25]. Therefore, the purpose of this investigation
was to study the eﬀects diﬀerences in the miRNA and mitochondrial
proﬁle between master athletes aged over 65 years old and age-mat-
ched controls.
2. Methods
2.1. Participants
We recruited 26 Master Athletes (10 female and 16 male) at the
European Veterans Athletics Championships in 2010 (Nyíregyháza,
Hungary). Control participants (n=18, 13 female, 5 male) were also
recruited. The participants provided written informed consent before
inclusion. For this study we have selected 10 master athletes 65 ± 5
years and 13 sedentary subjects 64.67 ± 2.08 years old. The master
athletes reported that they all had been training for more than sixty
years, while control subjects were sedentary.
The investigation was approved by the local ethics committee (File
number: 10826-0/2010-1018EKU, research permission number: 15/
07/2010-24/07/2010) and performed in compliance with the
Declaration of Helsinki.
2.2. Muscle biopsy
Muscle biopsies were obtained from the vastus lateralis using a
conchotome or needle biopsy technique as described earlier [26].
Samples were frozen in liquid nitrogen and stored at − 80 °C until
biochemical analysis.
2.3. RNA isolation
Total RNA, including miRNA, was isolated from muscle biopsy
samples by miRNeasy Mini Kit (Qiagen #217004) according to the
instructions of the manufacturer.
2.4. miRNA microarray analysis
miRNA expression analysis was performed on 4 samples from
master athletes (68.75 ± 8.54 years old) and 4 samples of sedentary
subjects (70.25 ± 11.3 years old) gained by skeletal muscle biopsy
samples with Agilent Human miRNA Microarray Release 14.0 8× 15K
resolution array (Agilent Technologies, USA), that distinguishes 887
human miRNAs. The microarray was performed according to the in-
structions by the manufacturer (Agilent miRNA microarray protocol
2.4). Hundred ng of total RNA were dephosphorylated and marked with
Cyanine-3-pCp dye using the miRNA Complete Labeling and Hyb Kit
(Agilent Technologies, USA). Puriﬁcation of the marked RNA was
performed by Micro Bio-Spin P-6 column (Bio-Rad Laboratories;
Hercules, CA, USA) and then hybridized onto the Human miRNA
Microarray Release 14.0 microarray slides. After hybridization, slides
were washed at room temperature and scanned using an Agilent DNA
microarray scanner. Raw data were extracted with the Agilent Feature
Extraction Software 11.0.
2.5. Detection of mature microRNAs in skeletal muscle
The TaqMan miRNA reverse transcriptase kit and TaqMan miRNA
assays (Applied Biosystems, Foster City, CA) were used to quantify
mature miRNA expression levels. Each target miRNA was quantiﬁed
according to the manufacturer's protocol with minor modiﬁcations.
Brieﬂy, reverse transcriptase reactions were performed with miRNA-
speciﬁc reverse transcriptase primers and 5 ng of puriﬁed total RNA for
30min at 16 °C, 30min at 42 °C, and ﬁnally 5min at 85 °C to heat-
inactivate the reverse transcriptase. All volumes suggested in the
manufacturer's protocol were halved, as previously reported [27]. Real-
time PCRs for each miRNA (10 μl total volumes) were performed in
triplicate, and each 10-μl reaction mixture included 2.4 μl of 10×-di-
luted reverse transcriptase product. Reactions were run on a PRISM
7900HT Fast Real-Time PCR System (Applied Biosystems) at 95 °C for
10min, followed by 40 cycles at 95 °C for 15 s and 60 °C for 1min.
Twofold dilution series were performed for all target miRNAs to verify
the linearity of the assay. To account for possible diﬀerences in the
amount of starting RNA, all samples were normalized to miR-423. All
reactions were run singleplex and quantiﬁed using the cycle threshold
(ΔΔCt) method [28].
2.6. mRNA expression levels
2.6.1. cDNA synthesis
cDNA was synthesized using a Tetro cDNA Synthesis kit (Bioline
#BIO-65026 Luckenwalde, Germany) in accordance with the manu-
factures’ instructions. Brieﬂy, the reaction conditions were as follows:
1 μg of RNA, 1 μl of random primers, 1 μl of 10mM dNTP, 1 μl of RNase
inhibitor, and 0.25 μl of 200 U/μl reverse transcriptase in a ﬁnal volume
of 20 μl. The solution was incubated for 10min at 25 °C for primer
annealing, followed by 42 °C for 60min for primer elongation, and
followed by 80 °C for 5min termination. cDNA samples were stored at
− 20 °C.
2.6.1.1. Real time quantitative RT-PCR (qRT-PCR) reaction. Based on the
principle of the SybrGreen detection method, EvaGreen® dye (Biotium,
Hayward, CA, USA) was used to detect PCR products. The PCR was
performed using a primer pair speciﬁc for mRNA of vascular
endothelial growth factor (VEGF), silent mating type information
regulation 2 homolog 1 (SIRT1), forkhead box protein O1 (FOXO1),
mitochondrial calcium uniporter (MCU, Insulin like growth factor (IGF-
1), peroxisome proliferator-activated receptor gamma coactivator 1-
alpha (PGC1α) and mechano growth factors (MGF) isoforms (for
sequences of mRNA genes used in the study see Table 1). PCR
ampliﬁcations consisted of equal amounts of template DNA, 10 μl of
ImmoMix™ complete ready-to-use heat-activated 2× reaction mix
(Bioline GmbH, Luckenwalde, Germany), 1 μl of 20x EvaGreen
(Biotium, Hayward, CA, USA), 2.5 μl of 10 nmol/L forward and
reverse primer (IBAGmbH, Göttingen, Germany) and water to a ﬁnal
volume of 20 μl. Ampliﬁcations were performed in a Rotor-Gene 6000
thermal cycler (Corbett Life Science/Qiagen, London, UK) at 95 °C for
10min, followed by 40 cycles of 95 °C for 10 s, 60 °C for 20 s and 72 °C
for 30 s in triplicates. The validity of the signal was evaluated by
melting analysis and agarose gel electrophoresis. Human 28 S rRNA
gene served as an endogenous control gene (Table 1).
Table 1
Reference genes.
H-28S-F AGCCGATCCATCATCCGCAATG
H-28S-R CAGCCAAGCTCAGCGCAAC
H-FOXO1-F AAGAGCGTGCCCTACTTCAA
H-FOXO1-R CATCCCCTTCTCCAAGATCA
H-IGF1/MGF-F CGAAGTCTCAGAGAAGGAAAGG
H-IGF1/MGF-R ACAGGTAACTCGTGCAGAGC
H-IGF1-F GCTCTTCAGTTCGTGTGTGGA
H-IGF1-R GCCTCCTTAGATCACAGCTCC
H-MCU-F CACTGTTGTGCCCTCTGATG
H-MCU-R ACTCTGTCAATTCCCCGATCC
H-PPARGC1A (PGC-1a)-F GTGAAGACCAGCCTCTTTGC
H-PPARGC1A (PGC-1a)-R TCACGTCTCCATCTGTCAGC
H-SIRT1-F TGCGGGAATCCAAAGGATAATTCAGTGTC
H-SIRT1-R CTTCATCTTTGTCATACTTCATGGCTCTATG
H-VEGFA-F AGGAGGAGGGCAGAATCATCA
H-VEGFA-R CTCGATTGGATGGCAGTAGCT
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2.7. Western blots
Tissue homogenates of the muscle biopsy samples were generated
with an Ultra Turrax® (IKA®-Werke) homogenizer using 10 vol of lysis
buﬀer (137mM NaCl, 20mM Tris-HCl, pH 8.0, 2% NP-40, 10% glycerol
and protease inhibitors). Five to ten micrograms of protein were elec-
trophoresed on 10–12% v/v polyacrylamide SDS-PAGE gels. Proteins
were electrotransferred onto polyvinylidene diﬂuoride (PVDF) mem-
branes. The membranes were subsequently blocked in 0.5% BSA, and
after blocking incubated with primary antibodies (SIRT3 1:2500 Abcam
#ab40006, SOD2 1:2500 Sigma-Aldrich #SAB1406465, Cytochrome
oxidase4 (COX4) (D-20) 1:2500 Santa Cruz #sc-69359, GAPDH
1:50000 Sigma-Aldrich #G8795) overnight at 4 °C. After incubation
with primary antibodies, membranes were washed in tris-buﬀered
saline-Tween-20 (TBST) and incubated with HRP-conjugated secondary
antibodies (1:50000, Jackson ImmunoResearch Europe Ltd). After in-
cubation with secondary antibodies, membranes were repeatedly wa-
shed. Membranes were incubated with chemiluminescent substrate
(Thermo Scientiﬁc, SuperSignal West Pico Chemiluminescent Substrate
#34080) and protein bands were visualized on X-ray ﬁlms. The bands
were quantiﬁed by ImageJ software, and normalized to GAPDH, which
served as an internal control.
2.8. Statistical analyses
Data gathered from the miRNA array validation and gene expression
experiments were analyzed with an unpaired Mann-Whitney U-test, and
unpaired, two-tailed Student's t-test or χ2 test were used for qPCR and
Western blot variables, as appropriate. Data are presented as mean ±
standard deviation. Signiﬁcance level was set at p < 0.05.
3. Results
First we performed miRNA array from the biopsy muscle samples of
Master athletes and control subjects. The microarray analysis revealed
that 21 of the 887 miRNA sequences were lower in the master athlete
than control muscles (Fig. 1). Four miRNA were selected based on the
greatest diﬀerence in the miRNA array (indicated in the box in Fig. 1)
for further q-PCR analysis. This revealed that only miR-7 was expressed
more (p < 0.05) in the muscles from controls than in those from
master athletes (Fig. 2).
Then from the remained muscle samples, key mitochondrial mRNA
(Fig. 3) and protein (Fig. 4) contents were measured. SIRT1 (p < 0.01)
and FOXO1 (p < 0.05) mRNA levels were higher in master athletes
than in control groups (Fig. 3), while the SIRT3 and SOD2 proteins
(p < 0.01; Fig. 4) from the muscle samples of master athletes were
higher than that in the control subjects.
4. Discussion
Aging is associated with an increased level of miR-7 and has been
Fig. 1. miRNA array proﬁle of master athletes and sedentary subjects, The array screened for 887 miRNA and 21 of them showed signiﬁcant diﬀerence (p < 0.05)
between sedentary and master athletes. Results are expressed mean ± SD, N=4 in each group.
Fig. 2. q-PCR results of miRNA levels, Four microRNA were selected to q-PCR
measurements and only miR-7 analysis showed signiﬁcant diﬀerence. Results
are expressed mean ± SD, N=4 in each group, *p < 0.05.
Fig. 3. mRNA levels of selected regulatory proteins in master athletes and se-
dentary subjects. The mRNA levels of seven key proteins were studied and
SIRT1 and FOXO1 mRNA levels were signiﬁcantly higher in skeletal muscle of
master athletes than is sedentary subjects. Results are expressed mean± SD,
N=10 in master athletes and N=13 in controls group. ** p < 0.01,
*p < 0.05.
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shown to play a crucial role in ageing-associated loss of transforming
growth factor-beta 1 dependent ﬁbroblast to myoﬁbroblast diﬀer-
entiation, and hence poorer wound healing [29]. It was proposed that
miR-7 up-regulation in aged cells reduced the expression of epidermal
growth factor receptor (EGFR) protein via degradation of its mRNA, but
it may also interact with the mRNA of downstream targets of the EGFR-
dependent signaling pathway such as MAPK/ERK, CaMKII, Rho-
GTPase, PI3K, Akt and mTOR [29]. This signaling pathway is important
to wound healing in skeletal muscle [30]. The signiﬁcance of miR-7 for
ﬁbroblast function is also illustrated by the diminished miR-7 level after
estradiol treatment that resulted increased EGFR mRNA expression and
restored functionality of aging ﬁbroblasts [31]. The cause of the se-
nescent state of the ﬁbroblasts and elevated miR-7 levels in old age has
been suggested to be involved in chronic inﬂammation and speciﬁcally
the interferon-linked pathway [31]. In line with the role of systemic
inﬂammation to induce miR-7 is the observation that miR-7 expression
is also elevated in airways of patients suﬀering from allergic rhinitis
[32] and chronic obstructive pulmonary disease [33], and in peripheral
blood mononuclear cells of HIV patient [34], conditions associated with
local or systemic inﬂammation. Moreover, it is known that faciosca-
pulohumeral muscular dystrophy is also associated with both in-
ﬂammation [35] and elevated miR-7 expression in muscle [36]. It is
thus possible that sarcopenia-associated inﬂammation may at least
partly contribute to the expression of miR-7 in old muscle. Exercise may
reduce systemic inﬂammation and expression of inﬂammatory markers
in muscle [37], the anti-inﬂammatory eﬀect of life-long exercise may
thus explain the lower miR-7 levels, we observed in the muscles of our
master athletes than in those of non-athletes.
Besides the role of miR-7 in inﬂammation, it seems that it is also
important to lipid metabolism. It has been shown that miR-7 mediates
cross-talk between peroxisome proliferator-activated receptor (PPAR),
sterol regulatory element-binding proteins (SREBP), and liver X re-
ceptors signaling pathways [38]. PPAR-α signaling regulates miR-7,
which activates SREBP. Down-regulation of miR-7 is associated with
sebaceous lipogenesis [39]. It is known that high level endurance per-
formance needs a high level of energy supply. Indeed, in mouse model,
which was developed to study extreme endurance, mice have sig-
niﬁcantly elevated levels of PPAR-α and lipogenesis [40], suggesting,
the regular exercise mediated metabolic challenge could involve miR-7-
mediated up-regulation of fat metabolism.
Another main ﬁnding of this study was, that in muscles from people
who performed life-long exercise SIRT3 protein levels were higher than
in the skeletal muscle of sedentary people. SIRT3 has a powerful reg-
ulatory role in lipid metabolism. SIRT3 ablation exhibits hallmarks of
fatty-acid oxidation disorders during fasting, including reduced ATP
levels [41]. Indeed, it has been shown that SIRT3 controls fatty acid
metabolism by deacetylation of medium-chain acyl-CoA dehydrogenase
and acyl-CoA dehydrogenase [42], therefore ablation of SIRT3 would
highly impact lipid metabolism. Moreover, it has been shown that
SIRT3 can interact and deacetylate ATP-synthase F-complex [43],
Fig. 4. Protein levels of SIRT3, SOD2 and COX4, immunoblot data revealed that SIRT3 and SOD2 levels of master athletes were signiﬁcantly elevated compared to
controls. Results are expressed mean ± SD, N=10 in master athletes and N=13 in controls group. ** p < 0.01, *p < 0.05.
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hence SIRT3 directly controls ATP production. This explains why SIRT3
knock-out mice have decreased production of ATP. In addition, it is also
known that the aging is associated with decline in SIRT3 levels [44],
which can explain the age related decline in ATP production. Here we
show that life-long physical exercise signiﬁcantly increases SIRT3 levels
and this is a powerful beneﬁcial eﬀect of exercise against age-associated
functional deterioration of mitochondria. SIRT3 deacetylates two cri-
tical lysine residues on SOD2 and promotes its antioxidant activity, and
decreases the level of ROS in the mitochondria [45]. Therefore, phy-
sical exercise through increase in SIRT3 level and activation of SOD2
can attenuate the age-associated decline in mitochondrial function and
suppress oxidative stress [46].
Due to the limited amount of samples, we could select just some
important proteins in the skeletal muscle to investigate the eﬀects of
life-long exercise training. According to our results the mRNA levels of
SIRT1 and FOXO1 were elevated in the muscle of master athletes
compared to control subjects. We and others have shown that exercise
training can prevent the age-related decrease in the level and activity of
SIRT1 and the associated functional alterations [12,17,47,48]. FOXO1
is involved in glycolytic and lipolytic ﬂux, and mitochondrial metabo-
lism, thus it is important part of adaptive response to cope with energy
challenge during exercise [49]. Moreover, it was suggested that the
deacetylation of FOXO1 by SIRT3 elevates the expression of the FOXO1
target genes, like SOD2 while decreasing senescence phenotypes [50].
In conclusion, our data suggest that life-long exercise program re-
sults in down-regulation of miR-7 in skeletal muscle of master athletes,
which can lead to suppression of sarcopenia related inﬂammation,
better fat metabolism. The increased level of SIRT3 supports more ef-
ﬁcient fat metabolism, ATP production and antioxidant capacity
through SOD2 in skeletal muscle of master athletes compared to con-
trols subjects. Life-long exercise attenuates the age-associated decline in
energy metabolism and antioxidant systems in the skeletal muscle.
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